Stock Chart
PTGX
Type: SELL wallstreet
Strike: $95
Premium: $3.80
Expiry: Apr 17, 2026
Target: $91
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About PTGX - Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Key Statistics
More PTGX Analysis
This PTGX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PTGX's price movements with trendlines, gamma walls, and key support/resistance levels.